
The global Medical Lateral Flow Assay (LFA) Testing Services market size was valued at USD 5249.7 million in 2023 and is forecast to a readjusted size of USD 7809.4 million by 2030 with a CAGR of 5.8% during review period.
The lateral flow assay (LFA) is a paper-based platform for the detection and quantification of analytes in complex mixtures, where the sample is placed on a test device and the results are displayed within 5–30 min.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The report includes an overview of the development of the Medical Lateral Flow Assay (LFA) Testing Services industry chain, the market status of Hospital (Sandwich Assays, Competitive Assays), Biopharmaceutical Company (Sandwich Assays, Competitive Assays), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Medical Lateral Flow Assay (LFA) Testing Services.
Regionally, the report analyzes the Medical Lateral Flow Assay (LFA) Testing Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Medical Lateral Flow Assay (LFA) Testing Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Medical Lateral Flow Assay (LFA) Testing Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Medical Lateral Flow Assay (LFA) Testing Services industry.
The report involves analyzing the market at a macro level:
Âé¶¹Ô´´ Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sandwich Assays, Competitive Assays).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Medical Lateral Flow Assay (LFA) Testing Services market.
Regional Analysis: The report involves examining the Medical Lateral Flow Assay (LFA) Testing Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Âé¶¹Ô´´ Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Medical Lateral Flow Assay (LFA) Testing Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Medical Lateral Flow Assay (LFA) Testing Services:
Company Analysis: Report covers individual Medical Lateral Flow Assay (LFA) Testing Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Medical Lateral Flow Assay (LFA) Testing Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Biopharmaceutical Company).
Technology Analysis: Report covers specific technologies relevant to Medical Lateral Flow Assay (LFA) Testing Services. It assesses the current state, advancements, and potential future developments in Medical Lateral Flow Assay (LFA) Testing Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Medical Lateral Flow Assay (LFA) Testing Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Âé¶¹Ô´´ Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Âé¶¹Ô´´ Segmentation
Medical Lateral Flow Assay (LFA) Testing Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Âé¶¹Ô´´ segment by Type
Sandwich Assays
Competitive Assays
Âé¶¹Ô´´ segment by Application
Hospital
Biopharmaceutical Company
Research Institute
Other
Âé¶¹Ô´´ segment by players, this report covers
Thermo Fisher
BD Biosciences
Abbott
Hologic, Inc.
PerkinElmer
Quidel Corporation
µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ
Oneida Research Services
Âé¶¹Ô´´ segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Medical Lateral Flow Assay (LFA) Testing Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Medical Lateral Flow Assay (LFA) Testing Services, with revenue, gross margin and global market share of Medical Lateral Flow Assay (LFA) Testing Services from 2019 to 2024.
Chapter 3, the Medical Lateral Flow Assay (LFA) Testing Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Medical Lateral Flow Assay (LFA) Testing Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Medical Lateral Flow Assay (LFA) Testing Services.
Chapter 13, to describe Medical Lateral Flow Assay (LFA) Testing Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Medical Lateral Flow Assay (LFA) Testing Services
1.2 Âé¶¹Ô´´ Estimation Caveats and Base Year
1.3 Classification of Medical Lateral Flow Assay (LFA) Testing Services by Type
1.3.1 Overview: Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Medical Lateral Flow Assay (LFA) Testing Services Consumption Value Âé¶¹Ô´´ Share by Type in 2023
1.3.3 Sandwich Assays
1.3.4 Competitive Assays
1.4 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ by Application
1.4.1 Overview: Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Biopharmaceutical Company
1.4.4 Research Institute
1.4.5 Other
1.5 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size & Forecast
1.6 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast by Region
1.6.1 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Region, (2019-2030)
1.6.3 North America Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.4 Europe Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.6 South America Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.1.4 Thermo Fisher Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 BD Biosciences
2.2.1 BD Biosciences Details
2.2.2 BD Biosciences Major Business
2.2.3 BD Biosciences Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.2.4 BD Biosciences Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.2.5 BD Biosciences Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.3.4 Abbott Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Hologic, Inc.
2.4.1 Hologic, Inc. Details
2.4.2 Hologic, Inc. Major Business
2.4.3 Hologic, Inc. Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.4.4 Hologic, Inc. Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.4.5 Hologic, Inc. Recent Developments and Future Plans
2.5 PerkinElmer
2.5.1 PerkinElmer Details
2.5.2 PerkinElmer Major Business
2.5.3 PerkinElmer Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.5.4 PerkinElmer Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.5.5 PerkinElmer Recent Developments and Future Plans
2.6 Quidel Corporation
2.6.1 Quidel Corporation Details
2.6.2 Quidel Corporation Major Business
2.6.3 Quidel Corporation Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.6.4 Quidel Corporation Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.6.5 Quidel Corporation Recent Developments and Future Plans
2.7 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ
2.7.1 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Details
2.7.2 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Major Business
2.7.3 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.7.4 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.7.5 µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ Recent Developments and Future Plans
2.8 Oneida Research Services
2.8.1 Oneida Research Services Details
2.8.2 Oneida Research Services Major Business
2.8.3 Oneida Research Services Medical Lateral Flow Assay (LFA) Testing Services Product and Solutions
2.8.4 Oneida Research Services Medical Lateral Flow Assay (LFA) Testing Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.8.5 Oneida Research Services Recent Developments and Future Plans
3 Âé¶¹Ô´´ Competition, by Players
3.1 Global Medical Lateral Flow Assay (LFA) Testing Services Revenue and Share by Players (2019-2024)
3.2 Âé¶¹Ô´´ Share Analysis (2023)
3.2.1 Âé¶¹Ô´´ Share of Medical Lateral Flow Assay (LFA) Testing Services by Company Revenue
3.2.2 Top 3 Medical Lateral Flow Assay (LFA) Testing Services Players Âé¶¹Ô´´ Share in 2023
3.2.3 Top 6 Medical Lateral Flow Assay (LFA) Testing Services Players Âé¶¹Ô´´ Share in 2023
3.3 Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´: Overall Company Footprint Analysis
3.3.1 Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´: Region Footprint
3.3.2 Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´: Company Product Type Footprint
3.3.3 Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´: Company Product Application Footprint
3.4 New Âé¶¹Ô´´ Entrants and Barriers to Âé¶¹Ô´´ Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Âé¶¹Ô´´ Size Segment by Type
4.1 Global Medical Lateral Flow Assay (LFA) Testing Services Consumption Value and Âé¶¹Ô´´ Share by Type (2019-2024)
4.2 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Forecast by Type (2025-2030)
5 Âé¶¹Ô´´ Size Segment by Application
5.1 Global Medical Lateral Flow Assay (LFA) Testing Services Consumption Value Âé¶¹Ô´´ Share by Application (2019-2024)
5.2 Global Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Forecast by Application (2025-2030)
6 North America
6.1 North America Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Type (2019-2030)
6.2 North America Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Application (2019-2030)
6.3 North America Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Country
6.3.1 North America Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Country (2019-2030)
6.3.2 United States Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.3 Canada Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.4 Mexico Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7 Europe
7.1 Europe Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Type (2019-2030)
7.2 Europe Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Application (2019-2030)
7.3 Europe Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Country
7.3.1 Europe Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Country (2019-2030)
7.3.2 Germany Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.3 France Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.4 United Kingdom Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.5 Russia Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.6 Italy Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Region
8.3.1 Asia-Pacific Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Region (2019-2030)
8.3.2 China Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.3 Japan Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.4 South Korea Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.5 India Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.6 Southeast Asia Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.7 Australia Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
9 South America
9.1 South America Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Type (2019-2030)
9.2 South America Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Application (2019-2030)
9.3 South America Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Country
9.3.1 South America Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
9.3.3 Argentina Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size by Country
10.3.1 Middle East & Africa Medical Lateral Flow Assay (LFA) Testing Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.4 UAE Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
11 Âé¶¹Ô´´ Dynamics
11.1 Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Drivers
11.2 Medical Lateral Flow Assay (LFA) Testing Services Âé¶¹Ô´´ Restraints
11.3 Medical Lateral Flow Assay (LFA) Testing Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Medical Lateral Flow Assay (LFA) Testing Services Industry Chain
12.2 Medical Lateral Flow Assay (LFA) Testing Services Upstream Analysis
12.3 Medical Lateral Flow Assay (LFA) Testing Services Midstream Analysis
12.4 Medical Lateral Flow Assay (LFA) Testing Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher
BD Biosciences
Abbott
Hologic, Inc.
PerkinElmer
Quidel Corporation
µþ¾±´Ç³¾Ã©°ù¾±±ð³Ü³æ
Oneida Research Services
Ìý
Ìý
*If Applicable.
